Cellective was developing several new pharmaceuticals treating B Cell related cancer and immune diseases. The technology is based on research by Founder Tom Tedder, Chairman of Immunology at Duke University.
35 West Watkins Mill Road
Maryland, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)